Press Release | Sun Jun 30, 2013 3:48pm EDT

Eliquis® (apixaban) Demonstrated Comparable Efficacy and Significantly Lower Rates of Major Bleeding in Patients Compared to Current Standard of Care for the Treatment of Acute Venous Thromboembolism

* Reuters is not responsible for the content in this press release.